SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Aug-16 10:00 PM View: | Organovo Holdings, Inc. (ONVO) | 17-Aug-16 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
19-Mar-15 4:40 PM View: | Allergan Plc (AGN) | 17-Mar-15 | Payment of Exercise | 549 | $307.51 | $168,823.00 | (26%) 2.09K to 1.54K | 53% |
13-May-14 5:12 PM View: | Allergan Plc (AGN) | 09-May-14 | Grant | 1,142 | $197.05 | $225,031.00 | 121% 0.95K to 2.09K | (26%) |
08-Nov-13 4:09 PM View: | Allergan Plc (AGN) | 06-Nov-13 | Market Sale | 300 | $157.34 | $47,202.00 | 46% 0.65K to 0.95K | (7%) |
03-Oct-13 4:45 PM View: | Allergan Plc (AGN) | 01-Oct-13 | Grant | 1,246 | -- | -- | 100% 0 to 1.25K | |
01-Oct-13 8:35 PM View: | Warner Chilcott Limited (WCRX) | 30-Sep-13 | Disposition | 4,170 | -- | -- | (100%) 4.17K to 0 | |
02-Jul-13 4:58 PM View: | Oxigene Inc. (OTLC) | 01-Jul-13 | Grant | 3,703 | -- | -- | 73% 5.06K to 8.76K | |
09-May-13 4:23 PM View: | Warner Chilcott Limited (WCRX) | 07-May-13 | Grant | 4,170 | -- | -- | 100% 0 to 4.17K | |
03-Jan-13 5:30 PM View: | Oxigene Inc. (OTLC) | 02-Jan-13 | Grant | 1,886 | -- | -- | 59% 3.17K to 5.06K | |
03-Jul-12 9:07 PM View: | Oxigene Inc. (OTLC) | 02-Jul-12 | Grant | 18,148 | -- | -- | 91% 19.91K to 38.06K | |
30-May-12 8:36 PM View: | Aradigm Corp (ARDM) | 25-May-12 | Grant | 50,000 | -- | -- | 61% 82.33K to 132.33K | |
04-Jan-12 5:05 PM View: | Oxigene Inc. (OTLC) | 02-Jan-12 | Grant | 10,101 | -- | -- | 103% 9.81K to 19.91K | |
02-Nov-11 4:14 PM View: | Oxigene Inc. (OTLC) | 31-Oct-11 | Grant | 6,061 | -- | -- | 162% 3.75K to 9.81K | |
31-May-11 7:52 PM View: | Aradigm Corp (ARDM) | 26-May-11 | Grant | 39,474 | -- | -- | 92% 42.86K to 82.33K | |
04-Jan-11 9:49 PM View: | Oxigene Inc. (OTLC) | 02-Jan-11 | Grant | 25,000 | $0.23 | $5,750.00 | 50% 50.0K to 75.0K | (99%) |
12-Nov-10 5:25 PM View: | Aradigm Corp (ARDM) | 03-Nov-10 | Grant | 42,857 | -- | -- | 100% 0 to 42.86K | |
06-Jul-10 7:18 PM View: | Oxigene Inc. (OTLC) | 01-Jul-10 | Market Sale | 25,000 | $0.39 | $9,750.00 | 100% 25.0K to 50.0K | (99%) |
06-Apr-10 11:47 AM View: | Oxigene Inc. (OTLC) | 02-Apr-10 | Grant | 25,000 | $1.17 | $29,250.00 | 100% 0 to 25.0K | (100%) |
04-Dec-06 2:39 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Dec-06 | Payment of Exercise | 3,038 | $24.74 | $75,160.10 | (4%) 74.5K to 71.47K | (168%) |
12-Sep-06 4:38 PM View: | Bristol-Myers Squibb Co. (BMY) | 08-Sep-06 | Payment of Exercise | 1,215 | $22.96 | $27,896.40 | (2%) 75.72K to 74.5K | (192%) |
24-May-06 11:09 AM View: | Bristol-Myers Squibb Co. (BMY) | 22-May-06 | Payment of Exercise | 3,038 | $24.16 | $73,398.10 | (4%) 78.76K to 75.72K | (181%) |
09-Mar-06 5:09 PM View: | Bristol-Myers Squibb Co. (BMY) | 07-Mar-06 | Grant | 13,192 | $22.73 | $299,854.00 | 20% 67.43K to 80.62K | 202% |
09-Mar-06 5:09 PM View: | Bristol-Myers Squibb Co. (BMY) | 07-Mar-06 | Payment of Exercise | 1,862 | $22.73 | $42,323.30 | (2%) 80.62K to 78.76K | (202%) |
06-Dec-05 3:31 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Dec-05 | Payment of Exercise | 3,294 | $21.69 | $71,446.90 | (5%) 70.72K to 67.43K | (220%) |
23-May-05 1:03 PM View: | Bristol-Myers Squibb Co. (BMY) | 20-May-05 | Payment of Exercise | 2,460 | $25.64 | $63,074.40 | (3%) 73.18K to 70.72K | (177%) |
03-Mar-05 10:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-05 | Grant | 7,778 | -- | -- | 12% 65.4K to 73.18K | |
06-Dec-04 2:21 PM View: | Bristol-Myers Squibb Co. (BMY) | 03-Dec-04 | Payment of Exercise | 2,460 | $24.06 | $59,187.60 | (4%) 67.86K to 65.4K | (202%) |
04-Mar-04 10:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Mar-04 | Grant | 7,778 | -- | -- | 13% 60.08K to 67.86K | |
12-Sep-03 10:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 10-Sep-03 | Grant | 10,000 | -- | -- | 20% 50.08K to 60.08K |